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Summary.-Three cell lines derived from adult rat liver have been used to study
changes in levels of y-glutamyl transferase (GGT), a possible marker for premalig-
nant transformation in liver in vivo. None of the cell lines was able to meta-
bolize aflatoxin B1 (AFB1) and treatment with AFB1 alone did not influence GGT
activity. However, treatment with microsomally activated AFB1 increased the level
of activity in a cell line (BL8L) derived from normal liver with very low levels of
GGT, by as much as 10-fold, and 5-fold in a cell line (ARL) also isolated from normal
rat liver, but which had subsequently undergone spontaneous transformation. Micro-
somes from rats pretreated with phenobarbitone were compared with those from
3-methylcholanthrene-treated animals. AFB1 activated by the former produced
larger increases in GGT activity, but in no case did the enzyme levels approach that
in a cell line (JBI) derived from a hepatoma in the liver of anAFB,-fed rat. Treatment
of JBI cells with microsomally activated AFB1 produced no further increase in
activity. Histochemical staining indicated an uneven distribution of enzyme in all
cell populations, both before and after treatment. This cell-culture system is useful
for further studies on the role of GGT in carcinogenesis.
INCREASED y-glutamyl transferase
(GGT) activity is associated with various
tumours, most consistently with those
induced in the rat by hepatocarcinogens
(Kalengayi et al., 1975; Solt et al., 1977;
Tsuchida et al., 1979; Fiala et al., 1980;
Lipsky et al., 1980; Shinozuka &Lombardi,
1980; Williams et al., 1.980). The early
and consistent appearance of the enzyme
during hepatocarcinogenesis in the rat is
of particular interest, since it is appar-
ently a marker for those cells from which
hepatomas eventually develop. However,
a direct relationship between GGT activity
and the carcinogenic process itself has not
yet been established. Therefore a better
understanding of the reason for the
increased GGT activity in premalignant
cells might be useful in the investigation
of the process of tumour development,
especially the very early and possibly
reversible stages, and in assessing the
usefulness of this enzyme as a marker.
One approach to this problem would be
to reproduce in cell culture those changes
in GGT activity which occur in vivo
during chronic carcinogen feeding.
Although there are many reports of
transformation of cultured cells by car-
cinogens, including aflatoxin B1 (AFB1)
(Toyoshima et al., 1970; DiPaolo et al.,
1972; Williams et al., 1973; Schaeffer &
Heintz, 1978), levels of GGT activity in
the cells have been measured in few
studies, and the results reported are
inconsistent. Cheng et al. (1978) did not
detect increased activity in "normal"
hepatocytes (i.e. cells isolated from an
untreated rat) in culture after treatment
with 4-nitroquinoline-1-oxide, and Laishes
et al. (1978) also reported that GGT
activity was not induced in primary
cultures ofhepatocytes exposed to various
carcinogens, including AFB1. However,
Lowing et al. (1979) reported an increase
in GGT activity in primary hepatocyte946M. M. AIANSON AND J. A. GREEN
cultures with a number of carcinogens,
and with two non-carcinogenic analogues,
and1 furthermore observed that "the
enhancement of enzyme activity at low
dose levels was due to generalized increases
in every cell rather than to selection of a
cell species particularly high in activity."
In the present study cultured epithelial-
type cells derived from rat liver have been
treated with a hepatocarcinogen and sub-
sequently examined for changes in levels
ofGGT activity. Aflatoxin B1 was selected,
firstly because it is one of the most
effective inducers in vivo of hepatic GGT
activity (Kalengayi et al., 1975) and
secondly because it was the agent used to
induce the hepatocellular carcinoma from
which one of the cell lines (JBI) was
derived.
MATERIALS AND METHODS
Cell lines.-The 3 cell lines used in this
study were derived from adult rat liver.
BL8L wAas obtained from a maintenance
hepatocyte culture isolated from a control
adult male Fischer 344 rat, whilst JBI was
derived from an AFB1-induced hepatocellular
carcinoma in the same strain (Judah et al.,
1977). ARL was a cell line (one of the IAR
series) from Dr R. Montesano, IARC, Lyon,
and derived from normal adult BD VI rat
liver. The epithelial nature of BL8L and JBI
cells was confirmed by ultrastructural exam-
ination (Manson et al., 1981). All cell lines
wiere grown in 100 mm plastic dishes in
Wllilliams Medium E (Flowr Laboratories,
Irvine, Ayrshire) supplemented with 500
foetal calf serum (FCS) (Sera-Lab, CrawNley
Down, Sussex) 2mM glutamine and 50 Mg
gentamicin/ml.
Pr-eparation of mnicrosomes. These were
obtained under sterile conditions from livers
of adult male Fischer 344 rats (body wt
-250 g) as described previously (Neal &
Colley, 1978) but omitting the final wash.
Microsomes wN-ere resuspended at a level of
250 mg original liver wAeight/400 yu micro-
somal suspension, containing 4-5 mg micro-
somal protein in 150mM KCI. Sterility of the
final preparations was checked by absence of
microbial growth on streaked agar plates.
Animals were pretreated wN-ith either 0.100
phenobarbitone (PB) in the drinking w%ater
for 5 days or 3-methyl-cholanthrene (3MC)
by i.p. injection (05 ml of a solution of
6 mg/ml in arachis oil, daily for 3 days).
Metabolism of AFB1 (Makor Chemicals
Inc., Jerusalem, Israel) by the 3 cell lines in
the presence and absence of microsomes
was examined by high-performance liquid
chromatography (HPLC) (Neal & Colley,
1978, 1979; Manson et al., 1981).
Treattment of cells with AFB1. Confluent
or near-confluent monolayers of cells grown
in 60mm-diameter plastic Petri dishes (3ml
medium, 3 x 106 cells) wTere used. The cul-
ture medium was removed and the cells were
treated with AFB1 in the presence of micro-
somal suspension and NADPH generating
system in medium without serum, usually for
2-3 h. The cells were then washed twice in
medium wAithout serum and returned to the
incubator (50 C02) in fresh medium contain-
ing 5Qo FCS. After 24 h (or in the case of
higher concentrations of AFB1, which were
slightly cytotoxic to BL8L cells, when the
cells had reformed a confluent monolayer)
plates were subcultured. BL8L and ARL
cultures were passaged 3 or 4 times before
harvesting, to ensure enough cells for quanti-
tative GGT assay. JBI cultures were pas-
saged twice. The time between treatment
and harvesting was 14-20 days for BL8L
and JBI cultures and 21-25 days for ARL
cultures. Cells were stored at -70TC before
assay.
Determination ofGGT activity. GGT activ-
ity was detected histochemically by a
modification of the method of Rutenberg
et al. (1969). Cultures were monitored at
various times after AFB1 treatment. The
enzyme activity was also determined quanti-
tatively in harvested cells by a modification
of the method of Smith et al. (1979) as pre-
viously described (Manson et al., 1981). For
BL8L and ARL cultures dilutions were made
from a suspension of 107 cells/ml, whilst
for JBI cultures the initial suspension was
105 cells/ml, giving 105-106 and 103-104 cells
respectively in the final assay sample.
RESULTS
31icroscomal activation of AFB1
As previously reported (Manson et al.,
1981) there was no metabolism of AFB1
(as shown bv HPLC) when the compound
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Frc. 1. HPLC separation of metabolites of AFBi, using microsomes prepared from rats pretreated
with (a) phenobarbitone and (b) 3-methylcholanthrene. Incubations were carried out in the
presence of 80mM Tris, since in the absence of such an acceptor the diol remains bound to micro-
somal protein.
TABLE 1.-GOT activities in the cultured
cell lines before treatment
Cell line
BL8L
ARL
JBI
nmol AMC/min/106 cells
0*024-0*164
0*593-2*234
28-330-64-722
Enzyme activity is expressed as nmol 7-amino-4-
methyl coumarin (AMC) formed/min/106 cells. Cells
were harvested by trypsinization, resuspended in
PBS at 10-20 x 106 cells/ml and stored at - 70°C
until use. The values shown indicate the range of
activities in each line. No nonspecific activity could
be measured when GGT was inhibited by serine-
borate (Tate & Meister, 1978).
alone was incubated with JBI or BL8L
cells. This was also found to be true for
the ARL cell line (unpublished). Addition
of a microsomal suspension was therefore
required to achieve metabolic activation
corresponding to the in vivo metabolism
of AFB1. Microsomal fractions were pre-
pared from the livers of rats pretreated
with either PB or 3MC. The metabolite
profile of AFB1 produced by these 2
preparations is shown in Fig. 1. Micro-
somes from untreated rats produce less of
all the metabolites (Metcalfe et al., 1981).
GGT activity of untreated cultures
Table I shows the range of control
levels of enzyme activity in various cul-
tures of the 3 cell lines. There was no
obvious relationship between level of
enzyme activity and passage number in
any ofthe lines. The sensitive fluorimetric
assay used in these experiments could
detect a very low level of activity in the
BL8L cells, but the activity at the lower
end of the BL8L range is close to the
limit of detection (0.05nmol/ml of 7-
amino-4-methyl coumarin (AMC). The
BL8L culture selected for use in the
present study was one possessing the
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FIG. 2. Monolayer cultures of (a) BL8L and (b) JBI cells grown orn glass coverslips, fixed for 15 min
with formel calcium and stained histochemicallv for GGT. In the BL8L culture a single small
patch of cells has stained darkly, whilst in the JBI culture all the cells are stained, some more than
others, anrd the stain also shows up clearly along the cell membranes on which most of the enzyme
is situated.
lowest level of control activity. Control
cultures of the JBI hepatoma cell line
contained at least 103 times the average
activity of the BL8L cells, whilst the
spontaneously transformed ARL line had
intermediate activity.
Histochemical staining ofGGT in mono-
layer cultures of each cell line, however,
indicated that the activity was not
uniformly distributed amongst the cells.
In a BL8L monolayer it was possible to
pick out a few GGT+ cells, some staining
darkly, whilst others stained only faintly.
Most cells, however, appeared to be
devoid of detectable activity (Fig. 2a). In
contrast, JBI hepatoma cells stained
heavily for GGT activity, and although
there was some variation in intensity of
stain, none of the cells was negative
(Fig. 2b). ARL cells were intermediate
between the JBI and BL8L cells, in that
many more cells were faintly stained than
in the BL8L cell line, but few stained as
darkly as most of the cells in the JBI
cultures. When injected s.c. into random-
bred female nude mice (nu.nu) BL8L cells
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TABLE II.-GGT activities in BL8L and JBI cells after treatment with AFB1 in
monolayer culture
Otlher
AFBI(/,g/ml) a(lditives AMiscrosomes
0o1
0-1,0-5
0-2
0.2,0-5
0o1
0 1,0-5
0-2
0-2,0-5
500 FCS
AS*
AS
AS
AS
AS
AS
AS
AS
AS
AS
3MC, PB
PB
PB
PB
PB
3MC
3MC
3AIC
3MC
nmol AMC/min/ 106 cells
BL8L
0-024+0-001
0-028+0-001
0-086+0-012
0-029+0-006
0-073+0-006
0-139+0-016
0-218+0-032
0263+0-031
0-028+0-003
0-135+0-027
0-034+0-002
0-071 +0005
% of
Treatment 1
JBI BL8L
55 30+3 84 100
58 20+3 85 117
55-21+2-88 358
56-60+2-71 121
304
579
908
64-68+6-38 1096
117
563
142
296
Eachi treatment was carriied out in duplicate aind values shown represent the meaIi of at least 4
determinations. All treatments (except 2, which include serum) were carried out in medium with-
out serum for 2 h. In treatments 6, 8, 10 and1 12, a second 2 h1 treatmeint was carried out with freshi
microsomes and AS 24 h later.
* NADPH-generating system.
TABLE III.-Increase in GGT
ARL cells after treatment wi
monolayer culture
AFB1
( g/ml)
0- 25
0-25
+0-75
Treatment
me(lium + 50, FCS
4 h
4 lh
3 h, non-conflueint
monolayei
Eaclh treatment was carrie(d out in
values shown represent the mean
determinations. All treatments witl
carried out in medium without ser
microsomes and NADPH-generating
second treatment in No. 3 was carri
later and only 3 h after subhulture.
did not produce tumours, bu
ARL cells did so within
(unpublished).
Effect of treatment with AFI
activity
Preliminary experiments de
that treatment of each cell line
in the absence of a microsoma
system did not increase GC
(results not shown).
BL8L monolayers were trea
twice with AFB1 in the presen
PB or 3MC microsomes. The GI
was measured in cells harves
passages (see Methods) after
7activity in Results (Table II) indicated that AFB1
th AFB1 in treatment in the presence of microsomes
increased GGT activity, that AFB1 acti-
nmol AMC/ vated by PB microsomes was more min/106 cells effective than when activated by 3MC
2-55+0-04 microsomes; that 2 successive treatments
were more effective than one; and that in
2 60 + ±0 06 all but the last treatment, the higher dose
was more effective. In this experiment a
of at least 4 small increase in GGT activity was
1i AFB1 were obtained in BL8L cultures to which only
;um, with PB the NADPH-generating system (AS) had sem oth4dea been added (Table II, treatment 3).
However, in a subsequent experiment in
which various amounts of AS (50-250 ,ul)
it JBI and were added to BL8L monolayers, no
3-5 weeks increase in GGT activity was found.
A similar experiment using the ARL
cell line demonstrated that GGT levels
V1 on GGT could also be increased in these cells,
when treated with activated AFB1 in
Xmonstrated monolayer culture (Table III). A second
with AFB1 treatment carried out on a non-confluent
1 activating (recently sub-cultured) culture 4 days
MT activity after the first treatment (Table III, treat-
ment 3) caused no further increase in
,ted once or GGT activity.
Lce of either When JBI cells, which already contain
GT activity a high level of GGT, were treated in the
;ted several manner which produced the largest
treatment. increase in BL8L cells, the subsequent
2
3
4
5
6
7
8
9
10
I1
12
JBI
100
105
99
102
117
3
3
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GGT activity was not significantly differ-
ent from the level in untreated cells grown
in complete medium (Table II).
In parallel with the quantititative
determinations of total GGT activity by
the fluorescence assay, GGT activity was
examined histochemically. Staining of
both BL8L and ARL cultures showed that
the increased enzyme activity induced by
treatment with activated AFB1 was not
uniformly distributed throughout the cul-
ture. BL8L cultures were stained 5 and
21 days after treatment. No increase in
activity was seen in control cultures
(treatments 1-4 in Table II) up to time
of harvesting. However, at 5 days in-
creased areas of activity were seen
with treatments 5, 7 and 9-12. Cultures
from treatments 6 and 8 had not reformed
a confluent monolayer after the first post-
treatment subculture. At 21 days and 3 or
4 passages after treatment, increased
activity could be seen histochemically in
cultures after treatments 5-12, as con-
firmed by quantitative assay.
The BL8L culture in which the increase
in activity was greatest (No. 8, Table II)
was stored in liquid N2 for 8 months,
revived and passaged a further 5 times,
at which time the activity was remeas-
ured. An approximately 5-fold increase
in activity over a control culture was
suggested by histochemical staining. This
was confirmed by quantitative assay
which gave a value of 0 104 + 0-015 nmol
AMC/min/106 cells.
DISCUSSION
Increases in GGT activity occur in the
livers of rats after feeding a wide range of
hepatocarcinogens. The results presented
here, using a sensitive fluorimetric analyti-
cal technique and a histochemical assay,
show that it is possible to demonstrate
clearly a similar increase in GGT activity
in 2 different hepatic epithelial cell lines
by treatment with the carcinogen AFB1.
Furthermore, the increased activity detec-
ted by the fluorimetric assay has been
shown to be non-uniformly distributed
amongst the cell population by the
histochemical study, which is similar to
the in vivo situation in the liver. This
response in cultured cells is more likely
to represent an induction of the enzyme
in cells which were previously devoid of
or very low in activity, rather than
selection of cells already containing high
activity, since an increase could be
observed histochemically in confluent cul-
tures (where the rate of cell division is
very low) with doses of AFB1 which did
not disrupt the confluent monolayer.
Because of the problem of spontaneous
transformation (Montesano et al., 1980)
and the suggestion that some cell lines
become GGT+ during adaptation to
culture conditions (Sirica et al., 1979) it
was decided to use a culture with as low
a background level of the enzyme as
possible, and to monitor it closely to
detect any spontaneous increase in GGT.
The activity in BL8L cultures is consis-
tently low (0-02-0-04 nmol AMC/min/106
cells) apart from one culture which
reached the level of 0 164 nmol AMC/
min/106 cells (Table I). The reason for the
increase in that particular culture is
unlikely to be due to nutrient deficiency
or overcrowding, since it was shown that
maintaining a BL8L culture on glass
coverslips in a confluent state for up to
2 weeks, with only an occasional medium
change produced no increase in GGT+
cells (unpublished). Nor was it due to
spontaneous transformation in a late
passage, since the BL8L culture with the
high GGT activity was passage 14, whilst
the culture used to obtain the results in
Table II was passage 19 (from a different
batch of the stored cell line).
Stability of the increased GGT activity
was indicated in those experiments in
which the increase produced by AFB1 in
BL8L cells was measured 3-4 passages
and 2-3 weeks after treatment. Results
showed that an increase was maintained
in the absence of continued exposure to
the carcinogen. After storage in liquid N2
for 8 months, it was still possible to
measure increased activity, though con-
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siderably less than at the initial harvest.
The cell lines used in this study have
lost their ability to metabolize AFB1, as
shown by the HPLC results (Manson et
al., 1981, and present study) and the lack
of effect of AFB1 on GGT levels in the
absence ofmicrosomes, indicates a require-
ment for metabolic activation of the
carcinogen. In the present study, micro-
somes from two sources (PB- and 3MC-
pretreated rats) previously found to have
different AFB1-activating capacity in vitro
(Metcalfe et al., 1981) were used.
Metabolism of AFB1 by PB microsomes
appeared to be more efficient at increasing
GGT activity than metabolism by 3MC
microsomes, correlating with greater
activation ofthe carcinogen by the former.
With regard to the actual levels of GGT
achieved, from the results in Table II it
can be seen that 0.2 ug/ml AFB1 was
more effective at increasing enzyme activ-
ity than 0-1 ,ug/ml, and a second treatment
with 0 5 .g/ml produced an even greater
increase in all but one of the treatments.
However, in none of the treatments used
to date did enzyme levels approach those
found in the JBI cell line, though it is
possible that with longer treatment times
and higher doses, such levels might be
approached. Higher doses of AFB1 alone
did not appear to be sufficient (unpub-
lished). No significant increase in GGT
activity could be detected with AFB1
treatment in the absence of microsomal
metabolism, nor was it possible to pro-
duce any significant increase in activity
in the JBI cell line with activated AFB1
at the levels used for the other cell lines.
The development of cell cultures is
important both for the assay of potential
chemical carcinogens and for studies on
the mechanism of chemical carcinogenesis.
The cell lines used in the present study
offer an opportunity to study the involve-
ment of GGT in the carcinogenic process.
The question which must be considered
is the significance of GGT in the develop-
ment of malignant hepatic tumours in the
rat. It has been suggested that the
increase in GGT activity in hepatocytes
in vivo indicates the acquired resistance
of these cells to the cytotoxic effects of
the carcinogen (Solt & Farber, 1976;
Tsuda et al., 1980), which in turn allows
them to proliferate preferentially in the
continuing presence of the carcinogen. It
has already been shown that the JBI
cells are more resistant to the cytotoxic
action of AFB1 than the BL8L cells
(Manson et al., 1981). Therefore by increas-
ing the GGT activity of the BL8L line,
as has been done in the present study, it
should be possible to examine whether
this confers resistance to the cytotoxic
effects of higher doses of AFB1, whether
this effect is confined to carcinogens, and
the degree to which resistance to the cyto-
toxic effects of one compound protects
against toxicity ofother compounds.
The enzyme appears to be one of the
most consistent markers, not only for the
development of primary liver neoplasms
in vivo, but also for transformed or
tumorigenic cells when these are reintro-
duced into an animal (Montesano et al.,
1980). Of the cell lines used in the present
study, the one with the lowest GGT levels
(BL8L) failed to produce tumours in nude
mice, whilst both ARL and JBI lines
produced tumours in 100% of animals
within a few weeks. Studies are in pro-
gress into the ability of AFB,-treated
BL8L cells with raised GGT levels to cause
tumour formation.
In view of the results from the present
study, on the uneven distribution of GGT
amongst an apparently homogeneous pop-
ulation, the possibility must be considered
that it is not the average GGT content of
the cell population, but the number of
cells with a higher-than-average GGT
activity which determines the tumorigenic
potential of a cell population. This can
only be resolved by separation of the cell
populations according to their GGT activ-
ity (e.g. flow cytometry). One possible
method along these lines has been out-
lined in a previous publication (Manson
etal., 1981).
Thie, autlioixs voul(1 like to thiank Dr. G. E. Neal
for helpful (discussion.
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